Skip to Content


MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

Main Content

Plenary Session 2202

From Basic Science to the Clinic: Atypical Parkinsonism (PSP, CBD, MSA)

Monday, August 28, 2023
11:00 – 13:00


In this session the faculty will demonstrate how our understanding of disease mechanisms from basic science informs clinical therapeutic trials in patients with PSP, CBD and MSA. Moreover, the speakers will present current management of people with atypical parkinsonism around the globe.

Pietro Cortelli, Italy 
Pramod Pal, India

Chin-Hsien Lin, Taiwan 

4R Tauopathies: PSP, CBD 
Gabor Kovacs, Canada 

Applying Best Medical Management Across the Globe
Marina Picillo, Italy

CSPC Liaison: 
Maria Stamelou, Greece

At the conclusion of this session, participants should be better able to:

  1. Explain how knowledge on a-synuclein-related disease mechanisms translates into clinical trials in MSA patients
  2. Describe the key biological processes in 4R tauopathies that are/will be targeted by clinical trials
  3. Design and apply the best medical and multidisciplinary management plan for PSP, CBD and MSA

Recommended Audience:
Clinician, Researcher / Basic Scientist, Health Professional (non-physician), Fellow / Resident / Student

Education Level:
Beginner/Foundational, Intermediate/Experienced

We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. Note: The MDS site uses related multiple domains, including and This cookie policy only covers the primary and domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice